Literature DB >> 12633659

Prostaglandin production from arachidonic acid and evidence for a 9,11-endoperoxide prostaglandin H2 reductase in Leishmania.

Zakayi Kabututu1, Samuel K Martin, Tomoyoshi Nozaki, Shin-ichiro Kawazu, Tetsuya Okada, Craig Joe Munday, Michael Duszenko, Michael Lazarus, Lucy W Thuita, Yoshihiro Urade, Bruno Kilunga Kubata.   

Abstract

Lysates of Leishmania promastigotes can metabolise arachidonic acid to prostaglandins. Prostaglandin production was heat sensitive and not inhibited by aspirin or indomethacin. We cloned and sequenced the cDNA of Leishmania major, Leishmania donovani, and Leishmania tropica prostaglandin F(2alpha) synthase, and overexpressed their respective 34-kDa recombinant proteins that catalyse the reduction of 9,11-endoperoxide PGH(2) to PGF(2alpha). Database search and sequence alignment showed that L. major prostaglandin F(2alpha) synthase exhibits 61, 99.3, and 99.3% identity with Trypanosoma brucei, L. donovani, and L. tropica prostaglandin F(2alpha) synthase, respectively. Using polymerase chain reaction amplification, Western blotting, and immunofluorescence, we have demonstrated that prostaglandin F(2alpha) synthase protein and gene are present in Old World and absent in New World Leishmania, and that this protein is localised to the promastigote cytosol.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12633659     DOI: 10.1016/s0020-7519(02)00254-0

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  15 in total

Review 1.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

2.  Polyunsaturated fatty acid metabolites: biosynthesis in Leishmania and role in parasite/host interaction.

Authors:  Lucie Paloque; Teresa Perez-Berezo; Anne Abot; Jessica Dalloux-Chioccioli; Sandra Bourgeade-Delmas; Pauline Le Faouder; Julien Pujo; Marie-Ange Teste; Jean-Marie François; Nils Helge Schebb; Malwina Mainka; Corinne Rolland; Catherine Blanpied; Gilles Dietrich; Justine Bertrand-Michel; Céline Deraison; Alexis Valentin; Nicolas Cenac
Journal:  J Lipid Res       Date:  2019-01-09       Impact factor: 5.922

3.  Role of prostaglandin F2α production in lipid bodies from Leishmania infantum chagasi: insights on virulence.

Authors:  Théo Araújo-Santos; Nilda E Rodríguez; Sara Moura-Pontes; Upasna Gaur Dixt; Daniel R Abánades; Patrícia T Bozza; Mary E Wilson; Valéria Matos Borges
Journal:  J Infect Dis       Date:  2014-05-21       Impact factor: 5.226

Review 4.  Bioactive lipids in Trypanosoma cruzi infection.

Authors:  Fabiana S Machado; Shankar Mukherjee; Louis M Weiss; Herbert B Tanowitz; Anthony W Ashton
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

5.  Trypanosoma cruzi Produces the Specialized Proresolving Mediators Resolvin D1, Resolvin D5, and Resolvin E2.

Authors:  Romain A Colas; Anthony W Ashton; Shankar Mukherjee; Jesmond Dalli; Oscar B Akide-Ndunge; Huan Huang; Mahalia S Desruisseaux; Fangxia Guan; Linda A Jelicks; Fabiane Matos Dos Santos; Jyothi Nagajyothi; Michael A Zingman; Jinet Reyes; Louis M Weiss; Charles N Serhan; Herbert B Tanowitz
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

Review 6.  Co-opting oxylipin signals in microbial disease.

Authors:  Mengyao Niu; Nancy P Keller
Journal:  Cell Microbiol       Date:  2019-06       Impact factor: 3.715

7.  Effect of Diethylcarbamazine (DEC) on prostaglandin levels in Wuchereria bancrofti infected microfilaraemics.

Authors:  T Sankari; S L Hoti; L K Das; V Govindaraj; P K Das
Journal:  Parasitol Res       Date:  2013-03-24       Impact factor: 2.289

8.  Identification of a functional prostanoid-like receptor in the protozoan parasite, Trypanosoma cruzi.

Authors:  Shankar Mukherjee; Nikaeta Sadekar; Anthony W Ashton; Huan Huang; David C Spray; Michael P Lisanti; Fabiana S Machado; Louis M Weiss; Herbert B Tanowitz
Journal:  Parasitol Res       Date:  2013-02-13       Impact factor: 2.289

9.  Structure of the inhibitor complex of old yellow enzyme from Trypanosoma cruzi.

Authors:  Keishi Yamaguchi; Naoki Okamoto; Keiji Tokuoka; Shigeru Sugiyama; Nahoko Uchiyama; Hiroyoshi Matsumura; Koji Inaka; Yoshihiro Urade; Tsuyoshi Inoue
Journal:  J Synchrotron Radiat       Date:  2010-11-12       Impact factor: 2.616

10.  Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease.

Authors:  Shankar Mukherjee; Fabiana S Machado; Huang Huang; Helieh S Oz; Linda A Jelicks; Cibele M Prado; Wade Koba; Eugene J Fine; Dazhi Zhao; Stephen M Factor; J Elias Collado; Louis M Weiss; Herbert B Tanowitz; Anthony W Ashton
Journal:  PLoS One       Date:  2011-02-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.